Trials / Completed
CompletedNCT06151379
Muscle Parameters and Pathological Response in Breast Cancer Patients
The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (actual)
- Sponsor
- Acıbadem Atunizade Hospital · Academic / Other
- Sex
- Female
- Age
- 29 Years – 72 Years
- Healthy volunteers
- —
Summary
The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.
Detailed description
In patients with operable breast cancer (BC) receiving neoadjuvant chemotherapy (NAC), the pathological response rate was found to be related to body composition. The success of complete pathologic response (pCR) is a known prognostic factor in BC patients treated with NAC. The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neoadjuvant therapy | To measure muscle mass and predict pCR to NAC and its effect on clinical outcomes. |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-09-30
- Completion
- 2023-10-20
- First posted
- 2023-11-30
- Last updated
- 2023-11-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06151379. Inclusion in this directory is not an endorsement.